The Net Margin of Vertex Pharmaceuticals Incorporated (VRTX) is
32.94%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-12-31 |
32.94%
|
| 2024-12-31 |
-4.86%
|
| 2023-12-31 |
36.68%
|
| 2022-12-31 |
37.20%
|
| 2021-12-31 |
30.92%
|
| 2020-12-31 |
43.70%
|
| 2019-12-31 |
28.27%
|
| 2018-12-31 |
68.80%
|
| 2017-12-31 |
10.59%
|
| 2016-12-31 |
-6.58%
|
| Ticker |
Name |
Value |
|
AMRN
|
Amarin Corporation PLC
|
-18.16%
|
|
BIIB
|
Biogen Inc.
|
13.07%
|
|
EXEL
|
Exelixis Inc
|
33.73%
|
|
MYGN
|
Myriad Genetics, Inc.
|
-44.38%
|
|
SRNE
|
Sorrento Therapeutics Inc
|
-912.10%
|
|
XNCR
|
Xencor, Inc.
|
-73.20%
|
|
ALXN
|
Alexion Pharmaceuticals Inc
|
9.94%
|
|
ARWR
|
Arrowhead Pharmaceuticals, Inc.
|
-160.64%
|
|
NVAX
|
Novavax, Inc.
|
39.19%
|
|
PTCT
|
PTC Therapeutics, Inc.
|
39.44%
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
-144.39%
|
|
ORGO
|
Organogenesis Holdings Inc.
|
6.56%
|
|
OPK
|
OPKO Health, Inc.
|
-37.19%
|
|
VIR
|
Vir Biotechnology, Inc.
|
-638.87%
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
-764.01%
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
10.83%
|
|
EXAS
|
Exact Sciences Corporation
|
-6.40%
|
|
INSM
|
Insmed Incorporated
|
-210.54%
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
16.73%
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
30.16%
|
|
CBPO
|
China Biologic Products Holdings Inc
|
29.04%
|
|
NTRA
|
Natera, Inc.
|
-9.03%
|
|
TWST
|
Twist Bioscience Corporation
|
-28.34%
|
|
VCEL
|
Vericel Corporation
|
5.98%
|
|
ACAD
|
Acadia Pharmaceuticals Inc.
|
36.49%
|
|
EDIT
|
Editas Medicine, Inc.
|
-395.01%
|
|
MORF
|
Morphic Holding Inc
|
-29192.90%
|